CARL — Carlsmed, Inc. Stock Price, Chart & AI Report

Positive Oct 14, 2026 • 13:00 UTC GlobeNewswire Inc. • Na

Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System

Carlsmed, Inc. announced the U.S. commercial launch of its aprevo® Lumbar Bi-lateral Posterior System at the North American Spine Society's 41st Annual Meeting. The launch follows a limited market evaluation that began in February 2026. The system leverages the company's AI-enabled software platform to deliver personalized spine fusion solutions, with endorsements from surgeons at University of Colorado and Mayo Clinic.

CARL spine surgery medical device AI-enabled technology personalized medicine product launch fusion system

Sentiment note

The company successfully launched a new product after completing initial human procedures, received positive endorsements from respected medical institutions (University of Colorado and Mayo Clinic), and is expanding its technology platform. The launch represents business growth and market expansion with clinical validation from experienced surgeons.

Positive Sep 15, 2026 • 23:00 UTC GlobeNewswire Inc. • Na

Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical

Carlsmed, Inc. filed a patent infringement lawsuit against DeGen Medical, Inc. in the U.S. District Court for the District of South Carolina, alleging infringement of eight patents related to AI-enabled personalized spine surgery implants, methods, and systems. Carlsmed is seeking injunctive relief and damages.

CARL patent infringement spine surgery AI-enabled medical technology intellectual property medical devices litigation

Sentiment note

Carlsmed is actively protecting its intellectual property and demonstrating strong patent portfolio strength. The company is taking legal action to defend its proprietary technology, which signals confidence in its innovations and competitive positioning in the spine surgery market.

Positive Dec 3, 2025 • 12:00 UTC GlobeNewswire Inc. • Carlsmed, Inc.

Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting

Carlsmed launched its aprevo® Technology Platform for cervical fusion surgeries, featuring AI-driven preoperative planning and 3D-printed patient-specific implants. The platform aims to improve surgical outcomes and precision in spine procedures.

CARL spine surgery AI personalized medicine medical technology cervical fusion

Sentiment note

Company launched innovative medical technology platform, completed first 50+ clinical cases, received positive clinical feedback, and demonstrated potential to transform spine surgery standard of care

Positive Sep 29, 2025 • 13:00 UTC GlobeNewswire Inc. • Mike Cordonnier

Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary

Carlsmed has appointed Jenifer Kamocsay as Chief Legal Officer and Secretary, bringing over two decades of corporate legal experience from life science and technology sectors to strengthen the company's leadership team.

CARL PRGS legal appointment corporate governance spine surgery AI technology

Sentiment note

Company is expanding leadership, strengthening organizational capabilities, and preparing for commercial launch with an experienced legal professional

Positive Sep 22, 2025 • 13:00 UTC GlobeNewswire Inc. • Mike Cordonnier

Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index

Carlsmed, a medical technology company specializing in AI-enabled personalized spine surgery solutions, was added to the Russell 2000 Index following its IPO in July 2025.

CARL AI spine surgery medical technology Russell 2000 Index IPO

Sentiment note

Company achieved significant milestone by being added to Russell 2000 Index, indicating growth potential and market recognition